Community/Retail

The data demonstrated that the lotion resulted in statistically significant reductions in both inflammatory and noninflammatory lesions compared to vehicle.

This week's featured pharmacist is Lisa Lohr, Pharm D, BCPS, BCOP, a Specialty Medication Therapy Management pharmacist specializing in oncology care.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Officials with the FDA announced Thursday approval of lanadelumab (Takhzyro) for treatment of hereditary angioedema (HAE).

A new HIV therapy demonstrated its efficacy in reducing the virus and boosting immunity in drug-resistant patients, according to a recent published study.

Buprenorphine with naloxone (Suboxone), an established treatment for opioid use disorder, has been increasingly used in states that chose to expand Medicaid eligibility under the Affordable Care Act, according to the results of a recent study.

Officials with the FDA have approved a topical eye drop containing cenegermin, the first drug indicated for the treatment of a rare disease affecting the cornea.

The latest recommendation from the United States Preventive Services Task Force said cervical cancer screening depends on a woman’s age and other factors.

An evolving pharmacy practice started with the the owners' vision, and worked backwards to become a reality.

According to a recent study, older adults and Hispanics are less likely to receive HIV testing, indicating an urgent need for improved interventions.

Officials with the FDA have expanded the indication of pembrolizumab (Keytruda, Merck) for patients with metastatic, non-squamous non-small cell lung cancer (NSqNSCLC).

Officials with the FDA approved have approved stiripentol (Diacomit) for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.

The FDA said that it has extended expiration dates on some EpiPen and generic versions, all manufactured by Pfizer, by 4 months.

Pharmacy students should take the pressure off themselves and think about their next steps, not the rest of their careers.

The prescribing limits are designed to help prevent patients from receiving unnecessary opioid pills after surgery.

The CDC is Partnering with the American Optometric Association to bring inform patients about proper lens care, during Contact Lens Awareness Week.

In this clip, Kimberly Wu, a PharmD candidate at the Rutgers University Ernest Mario School of Pharmacy, discusses why it is important for pharmacy students to be proactive in their education, activities, and work.

Officials with the FDA have given approval for marketing Brainsway’s Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

Sun Pharmaceutical's cyclosporine ophthalmic solution is the first and only dry eye treatment to combine cyclosporine A with nanomicellar technology, according to the company.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A young patient, aged 11 months, suffered a stroke after being infected with the varicella zoster virus, commonly known as chickenpox.

Officials with the FDA have approved lenvatinib capsules (Lenvima, Eisai Inc.) for first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).

The FDA has approved the first generic epinephrine auto-injector for the emergency treatment of allergic reactions, including anaphylaxis.

The life-saving opioid antagonist Narcan is playing a key role during a mass overdose in the Connecticut city.

health care reimbursements for medications in the United States are not consistently aligned with their value or net health benefits, according to a new study.

States that chose to expand Medicaid eligibility under the Affordable Care Act (ACA) have seen a greater decrease in uninsured rates among low-income patients with substance use disorders than states that did not expand Medicaid.

What to consider when considering a smart bottle program.

Researchers have developed a novel peptide drug called FFW that could potentially reduce tumor growth and slow progression of liver cancer.